[go: up one dir, main page]

CY1111983T1 - Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο - Google Patents

Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο

Info

Publication number
CY1111983T1
CY1111983T1 CY20111100835T CY111100835T CY1111983T1 CY 1111983 T1 CY1111983 T1 CY 1111983T1 CY 20111100835 T CY20111100835 T CY 20111100835T CY 111100835 T CY111100835 T CY 111100835T CY 1111983 T1 CY1111983 T1 CY 1111983T1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical composition
antificial
agent
combination
general formula
Prior art date
Application number
CY20111100835T
Other languages
English (en)
Inventor
Nobuhiko Nomura
Hiroshi Nishikawa
Noritomo Fujino
Original Assignee
Toyama Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co., Ltd. filed Critical Toyama Chemical Co., Ltd.
Publication of CY1111983T1 publication Critical patent/CY1111983T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Φαρμακευτική σύνθεση περιέχουσα έναν ή περισσότερους αντιμηκυτιακούς παράγοντες που επιλέγονται από παράγωγο αρυλαμιδίνης που αντιπροσωπεύεται από το γενικό τύπο:
CY20111100835T 2005-04-07 2011-08-30 Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο CY1111983T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005110784 2005-04-07
EP06731152A EP1867332B1 (en) 2005-04-07 2006-04-05 Pharmaceutical composition and method using antifungal agent in combination

Publications (1)

Publication Number Publication Date
CY1111983T1 true CY1111983T1 (el) 2015-11-04

Family

ID=37086920

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100835T CY1111983T1 (el) 2005-04-07 2011-08-30 Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο

Country Status (19)

Country Link
US (1) US8993603B2 (el)
EP (1) EP1867332B1 (el)
JP (1) JP5216323B2 (el)
KR (1) KR101325620B1 (el)
CN (1) CN101151032B (el)
AU (1) AU2006234228B2 (el)
BR (1) BRPI0607910A2 (el)
CA (1) CA2602121C (el)
CY (1) CY1111983T1 (el)
DK (1) DK1867332T3 (el)
ES (1) ES2368078T3 (el)
NO (1) NO339713B1 (el)
NZ (1) NZ561675A (el)
PL (1) PL1867332T3 (el)
PT (1) PT1867332E (el)
RU (1) RU2396955C2 (el)
SI (1) SI1867332T1 (el)
WO (1) WO2006109642A1 (el)
ZA (1) ZA200708530B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080027908A (ko) * 2005-06-30 2008-03-28 프로시디온 리미티드 Ｇｐｃｒ 효능제
DK1967190T3 (da) * 2005-12-29 2010-11-22 Toyama Chemical Co Ltd Nyt arylamidin-derivat, salt deraf og svampebekæmpelsesmiddel indeholdende dette
KR101409258B1 (ko) * 2006-10-06 2014-06-18 토야마 케미칼 컴퍼니 리미티드 페닐아미딘 유도체를 함유하는 의약조성물 및 항진균제를 조합하여 사용하는 방법
CN103179970B (zh) * 2010-09-30 2015-11-25 富山化学工业株式会社 透皮吸收制剂
CA2840215A1 (en) 2011-06-22 2012-12-27 Abhijit S. BAPAT Conjugate-based antifungal and antibacterial prodrugs
AU2014276460A1 (en) 2013-06-04 2015-12-24 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
KR101658365B1 (ko) 2015-06-10 2016-09-22 주식회사 케어사이드 피부 감염의 예방 및 치료용 조성물
CN109689028A (zh) * 2016-07-12 2019-04-26 马丁尼斯生物制药纳米技术公司 用于中枢神经系统递送和治疗隐球菌感染的脂质卷包封的抗真菌化合物
WO2019118527A1 (en) * 2017-12-14 2019-06-20 The Johns Hopkins University Novel anti-fungal inhibitors
CN110269939A (zh) * 2019-03-12 2019-09-24 武汉愔紫生物科技有限公司 一种治疗真菌分泌蛋白介导的炎症疾病标志物的药物、药物组合物、用途及其使用方法
WO2021006317A1 (ja) * 2019-07-11 2021-01-14 株式会社セレンファーマ プロトテカ症の新規治療剤
BR112022024697A2 (pt) * 2020-06-03 2023-03-07 Ishihara Sangyo Kaisha Agente antimicrobiano para animal não humano

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2939292A1 (de) * 1979-09-28 1981-04-09 Boehringer Mannheim Gmbh, 6800 Mannheim N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
JP2865722B2 (ja) 1989-08-14 1999-03-08 日産自動車株式会社 カチオン電着塗料組成物
JPH03288051A (ja) 1990-03-30 1991-12-18 Mazda Motor Corp カムシャフトおよびその製造方法
GB9509631D0 (en) 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
WO1998010782A1 (en) 1996-09-12 1998-03-19 Merck & Co., Inc. Antifungal combination therapy
AUPQ066399A0 (en) 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
AU2003211692B2 (en) * 2002-03-06 2009-01-15 Toyama Chemical Co., Ltd. Novel arylamidine derivative or salt thereof
JP4937506B2 (ja) * 2003-09-05 2012-05-23 富山化学工業株式会社 新規なアリールアミジン誘導体またはその塩
PT1767526E (pt) 2004-06-30 2012-12-10 Toyama Chemical Co Ltd Derivado de arilamidina, os seus sais e um antifúngico que os contenha

Also Published As

Publication number Publication date
PL1867332T3 (pl) 2012-01-31
NO339713B1 (no) 2017-01-23
DK1867332T3 (da) 2011-09-19
CN101151032B (zh) 2011-06-22
PT1867332E (pt) 2011-11-03
WO2006109642A1 (ja) 2006-10-19
NZ561675A (en) 2010-07-30
EP1867332A4 (en) 2010-01-27
EP1867332A1 (en) 2007-12-19
AU2006234228A1 (en) 2006-10-19
CN101151032A (zh) 2008-03-26
RU2007141162A (ru) 2009-05-20
KR20080002854A (ko) 2008-01-04
ES2368078T3 (es) 2011-11-14
KR101325620B1 (ko) 2013-11-06
EP1867332B1 (en) 2011-08-24
JP5216323B2 (ja) 2013-06-19
CA2602121C (en) 2014-09-23
NO20074723L (no) 2007-12-28
US20090087480A1 (en) 2009-04-02
AU2006234228B2 (en) 2011-05-26
JPWO2006109642A1 (ja) 2008-11-13
BRPI0607910A2 (pt) 2010-03-23
RU2396955C2 (ru) 2010-08-20
CA2602121A1 (en) 2006-10-19
US8993603B2 (en) 2015-03-31
ZA200708530B (en) 2009-04-29
SI1867332T1 (sl) 2011-11-30

Similar Documents

Publication Publication Date Title
CY1111983T1 (el) Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο
CY1121162T1 (el) M-csf-ειδικο μονοκλωνικο αντισωμα και χρησεις αυτου
CY2017040I2 (el) Συνθεσεις και μεθοδοι για διαμορφωση ματισματος smn2
CY2017027I2 (el) Σταθεροποιημενες συνθεσεις πτητικων αλκυλιωτικων παραγοντων και μεθοδοι χρησης αυτων
CY1112225T1 (el) Ενωσεις κυκλικης αμινης και παραγων ελεγχου ζιζανιων
CY1110026T1 (el) Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων
CY1112886T1 (el) Ανοσοκατασταλτικος παραγοντας ο οποιος περιλαμβανει μια ετεροκυκλικη ενωση ως δραστικο συστατικο
CY1110392T1 (el) Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης
ECSP077335A (es) Inhibidores de la interaccion entre mdm2 y p53
CY2019042I2 (el) Οφθαλμολογικες συνθεσεις και η χρηση τους
ECSP088246A (es) Nuevos derivados de benzotiazolona
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
ATE426599T1 (de) Thiazolylpiperidin derivate als mtp inhibitoren
PA8667201A1 (es) Nuevos compuestos farmaceuticos
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
UY31145A1 (es) Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
DK3543310T3 (da) Sammensætninger omfattende hfc-1234yf og hfc-32
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
SE0301650D0 (sv) Novel compounds
UY29712A1 (es) Sal de derivado de piperidina, composición farmacéutica que la contiene y aplicaciones
CY1108585T1 (el) Συνθεσεις ζιζανιοκτονου βασισμενες σε 3-φαινυλουρακιλες και 3-σουλφονυλισοξαζολινες
DK2070536T3 (da) Farmaceutisk sammensætning med et phenylamidin-derivat og fremgangsmåde til anvendelse af den farmaceutiske sammensætning i kombination med et antifungalt middel
EA200801139A1 (ru) Композиция для аэрозольной ингаляции